频繁影像检查是否必要?非转移性肾细胞癌手术治疗后随访中计算机断层扫描的影响:一项系统综述
该系统综述检索截至2024年5月29日的文献,纳入20项非转移性肾细胞癌根治性手术后的研究,比较高于2022年欧洲泌尿外科学会(EAU)指南推荐频率的CT随访与遵循指南随访的复发和生存数据。多数研究(16项,80%)采用高于指南的影像频率,低危研究复发率0-7.6%,高危研究复发率在随机对照试验中为33%-40%、回顾性研究中为11%-28%。作者认为更频繁影像可能并无优势,但需高质量证据进一步改进指南。
要点
- 16项(80%)研究随访CT频率高于2022年EAU指南推荐,2项(10%)遵循指南,2项(10%)低于指南。
- 低危研究复发率0-7.6%,高危研究复发率随机对照试验33%-40%、回顾性研究11%-28%。
- 不同影像频率研究的生存和复发率相似,更频繁影像可能并无优势。
核心结论
- 多数研究在非转移性肾细胞癌治疗后随访中采用高于2022年EAU指南推荐的影像频率。
- 生存和复发率提示高于EAU推荐的更频繁影像可能并无优势,但需高质量证据进一步改进指南。
研究设计与样本
- 系统综述,检索PubMed/Medline和EMBASE截至2024年5月29日。
- 纳入描述非转移性肾细胞癌经部分或根治性肾切除术治愈性治疗患者的研究。
- 将CT扫描次数高于EAU推荐的研究与遵循指南的研究进行比较,检查复发和生存数据。
- 共20项研究符合纳入标准。
主要发现
- 16项(80%)研究随访影像频率高于2022年EAU指南推荐,2项(10%)遵循指南,2项(10%)影像少于指南。
- 低危研究复发罕见(0-7.6%)。
- 高危研究复发率在随机对照试验中为33%-40%,在回顾性研究中为11%-28%。
关键数值与推荐
- 结局按2022年EAU指南分为风险组。
临床怎么用
- 原文未据此给出推荐。
局限性
- 由于临床多样性,不适合进行Meta分析。
- 队列研究偏倚风险高。
- 需要高质量证据以进一步改进指南。
- 需要前瞻性研究以确定随访期间影像能否进一步减少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Current guidelines on radiological follow-up (FU) for patients after treatment for nonmetastatic renal cell carcinoma (RCC) are not based on robust evidence. This review aims to evaluate whether the 2022 European Association of Urology (EAU) guidelines are noninferior, in terms of recurrence and (overall) survival, to a higher imaging frequency of computed tomography (CT) of the chest and abdomen. METHODS: A literature search of relevant search machines (PubMed/Medline and EMBASE) was performed up to May 29, 2024. Studies describing patients with nonmetastatic RCC who underwent curative treatment by means of partial or radical nephrectomy were included. Studies with a higher number of CT scans than recommended by the EAU were compared with those that followed guidelines by examining recurrences and survival data. Outcomes were classified into risk groups according to the 2022 EAU guidelines. KEY FINDINGS AND LIMITATIONS: Twenty studies met our inclusion criteria. Sixteen (80%) studies employed a higher imaging frequency during FU compared with 2022 EAU guideline recommendations, two studies (10%) followed the guidelines, and two studies (10%) performed less imaging. Recurrences were rare in low-risk studies (0-7.6%) and varied among high-risk studies, ranging between 33% and 40% in randomized controlled trials and 11% and 28% in retrospective studies. A meta-analysis was not suited due to clinical diversity, and the risk of bias was high among cohort studies. CONCLUSIONS AND CLINICAL IMPLICATIONS: Most studies employ a higher imaging frequency during FU after treatment for nonmetastatic RCC than recommended by the 2022 EAU guidelines. Survival and recurrence rates suggest that more frequent imaging than recommended by the EAU may not be advantageous, although high-quality evidence is needed to further improve guidelines. PATIENT SUMMARY: In this review, we assessed radiological follow-up schedules for patients after surgery for kidney cancer and compared these with the follow-up schedules recommended by the European Association of Urology guidelines. We found that most studies apply more frequent imaging during follow-up than recommended by guidelines, although survival and recurrence rates are similar among studies with different imaging frequencies. We conclude that more frequent imaging than recommended by guidelines may not be necessary and that prospective studies are needed to determine whether imaging can be reduced further during follow-up.
引用
- van den Brink L, Reijerink MAA, Henderickx MMEL, et al. Is Frequent Imaging Necessary? Impact of Computed Tomography During Follow-up After Surgical Treatment for Nonmetastatic Renal Cell Carcinoma: A Systematic Review. Eur Urol Oncol. 2024. PMID: 39665918. doi:10.1016/j.euo.2024.11.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。